4.5 Article

Outbreak of hepatitis A linked to European outbreaks among men who have sex with men in Osaka, Japan, from March to July 2018

期刊

HEPATOLOGY RESEARCH
卷 49, 期 6, 页码 705-710

出版社

WILEY
DOI: 10.1111/hepr.13314

关键词

hepatitis A; men who have sex with men; outbreak

向作者/读者索取更多资源

Aim Ongoing hepatitis A outbreaks among men who have sex with men (MSM) have been reported worldwide, mainly in Europe, since 2016. In Japan, there has been an increase in the number of notified hepatitis A cases since January 2018, most of which were suspected to have been transmitted through homosexual contact. In this paper, we describe the current outbreak situation of hepatitis A among MSM. Methods Between March and July 2018, 13 cases of hepatitis A were identified in our hospital. All cases were identified as MSM. Data on clinical and laboratory findings and therapies were collected from medical records. Serum or stool samples were obtained from 13 patients and subjected to sequence analysis. Results Of all patients, 12 reported to have male-to-male homosexual contact within 7 weeks prior to symptom onset, and 6 visited sex-on-premises venues in the same area. Furthermore, 12 patients were infected with HIV and consequently received antiretroviral therapy with sustained viral suppression. Ten patients received pulsed methylprednisolone therapy. Plasma exchange was additionally carried out in one patient. All patients received inpatient hospital care and were discharged alive. Sequence information, which was available in all cases, showed that the hepatitis A virus strain was identical to the EuroPride strain (RIVM-HAV16-090). Conclusions Results of sequence analysis suggest that the ongoing hepatitis A outbreak among MSM in Japan is linked to the 2016 European outbreaks. A vaccination program is urgently required for high-risk populations to control this ongoing outbreak.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

S100A8 Production in CXCR2-Expressing CD11b+Gr-1high Cells Aggravates Hepatitis in Mice Fed a High-Fat and High-Cholesterol Diet

Kaori Mukai, Takuya Miyagi, Kumiko Nishio, Yoshinobu Yokoyama, Teppei Yoshioka, Yoshinobu Saito, Satoshi Tanaka, Minoru Shigekawa, Takatoshi Nawa, Hayato Hikita, Ryotaro Sakamori, Harumasa Yoshihara, Yasuharu Imai, Naoki Hiramatsu, Tomohide Tatsumi, Tetsuo Takehara

JOURNAL OF IMMUNOLOGY (2016)

Article Gastroenterology & Hepatology

Rubicon Inhibits Autophagy and Accelerates Hepatocyte Apoptosis and Lipid Accumulation in Nonalcoholic Fatty Liver Disease in Mice

Satoshi Tanaka, Hayato Hikita, Tomohide Tatsumi, Ryotaro Sakamori, Yasutoshi Nozaki, Sadatsugu Sakane, Yuto Shiode, Tasuku Nakabori, Yoshinobu Saito, Naoki Hiramatsu, Keisuke Tabata, Tsuyoshi Kawabata, Maho Hamasaki, Hidetoshi Eguchi, Hiroaki Nagano, Tamotsu Yoshimori, Tetsuo Takehara

HEPATOLOGY (2016)

Article Biochemistry & Molecular Biology

DNase II activated by the mitochondrial apoptotic pathway regulates RIP1-dependent non-apoptotic hepatocyte death via the TLR9/IFN-β signaling pathway

Yoshinobu Saito, Hayato Hikita, Yasutoshi Nozaki, Yugo Kai, Yuki Makino, Tasuku Nakabori, Satoshi Tanaka, Ryoko Yamada, Minoru Shigekawa, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara

CELL DEATH AND DIFFERENTIATION (2019)

Article Gastroenterology & Hepatology

Synthetic lethal interaction of combined CD26 and Bcl-xL inhibition is a powerful anticancer therapy against hepatocellular carcinoma

Tsukasa Kawaguchi, Takahiro Kodama, Hayato Hikita, Yuki Makino, Yoshinobu Saito, Satoshi Tanaka, Satoshi Shimizu, Ryotaro Sakamori, Takuya Miyagi, Hiroshi Wada, Hiroaki Nagano, Naoki Hiramatsu, Tomohide Tatsumi, Tetsuo Takehara

HEPATOLOGY RESEARCH (2015)

Article Multidisciplinary Sciences

Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver

Tasuku Nakabori, Hayato Hikita, Kazuhiro Murai, Yasutoshi Nozaki, Yugo Kai, Yuki Makino, Yoshinobu Saito, Satoshi Tanaka, Hiroshi Wada, Hidetoshi Eguchi, Takeshi Takahashi, Hiroshi Suemizu, Ryotaro Sakamori, Naoki Hiramatsu, Tomohide Tatsumi, Tetsuo Takehara

SCIENTIFIC REPORTS (2016)

Article Gastroenterology & Hepatology

Favorable outcome with direct-acting antiviral treatment in hepatitis C patients coinfected with HIV

Hisashi Ishida, Akio Ishihara, Satoshi Tanaka, Tetsuya Iwasaki, Hiroko Hasegawa, Tomofumi Akasaka, Yuko Sakakibara, Shoichi Nakazuru, Tomoko Uehira, Takuma Shirasaka, Eiji Mita

HEPATOLOGY RESEARCH (2019)

Article Multidisciplinary Sciences

Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activation

Yuto Shiode, Hayato Hikita, Satoshi Tanaka, Kumiko Shirai, Akira Doi, Sadatsugu Sakane, Yugo Kai, Tasuku Nakabori, Ryoko Yamada, Takahiro Kodama, Ryohei Narumi, Ryotaro Sakamori, Hidetoshi Eguchi, Takeshi Tomonaga, Tomohide Tatsumi, Tetsuo Takehara

SCIENTIFIC REPORTS (2020)

Article Oncology

ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma

Yuta Myojin, Takahiro Kodama, Kazuki Maesaka, Daisuke Motooka, Yu Sato, Satoshi Tanaka, Yuichi Abe, Kazuyoshi Ohkawa, Eiji Mita, Yoshito Hayashi, Hayato Hikita, Ryotaro Sakamori, Tomohide Tatsumi, Ayumu Taguchi, Hidetoshi Eguchi, Tetsuo Takehara

Summary: The study identified FGF19 as a tumor biomarker indicating susceptibility to lenvatinib in HCC, and ST6GAL1 as a potential novel biomarker for identifying FGF19-driven HCC that is responsive to lenvatinib. Among patients with high serum ST6GAL1 levels undergoing TKI therapy, lenvatinib showed significantly better survival outcomes compared to sorafenib.

CLINICAL CANCER RESEARCH (2021)

Article Multidisciplinary Sciences

Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration

Yasutoshi Nozaki, Hayato Hikita, Satoshi Tanaka, Kenji Fukumoto, Makiko Urabe, Katsuhiko Sato, Yuta Myojin, Akira Doi, Kazuhiro Murai, Sadatsugu Sakane, Yoshinobu Saito, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara

Summary: This study found that enhanced tumor formation from DEN-transformed hepatocytes by persistent hepatocyte apoptosis is mediated by increased oxidative stress, independent of compensatory liver regeneration. Controlling oxidative stress may play a critical role in suppressing hepatocarcinogenesis for patients with livers harboring transformed cells.

SCIENTIFIC REPORTS (2021)

Article Virology

Prolonged Gut Dysbiosis and Fecal Excretion of Hepatitis A Virus in Patients Infected with Human Immunodeficiency Virus

Aya Ishizaka, Michiko Koga, Taketoshi Mizutani, Lay Ahyoung Lim, Eisuke Adachi, Kazuhiko Ikeuchi, Ryuta Ueda, Haruyo Aoyagi, Satoshi Tanaka, Hiroshi Kiyono, Tetsuro Matano, Hideki Aizaki, Sachiyo Yoshio, Eiji Mita, Masamichi Muramatsu, Tatsuya Kanto, Takeya Tsutsumi, Hiroshi Yotsuyanagi

Summary: This study comprehensively observed the amount of virus excreted into the intestinal tract, changes in the intestinal microbiome, and the level of inflammation during the healing process in patients with HAV infection. The results showed that the virus could be shed for more than 150 days post-infection, pro-inflammatory cytokines were elicited immediately after infection and dysbiosis of the intestinal microbiome occurred and continued for a long time after healing.

VIRUSES-BASEL (2021)

Article Oncology

Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy

Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori, Kazuki Maesaka, Takayuki Matsumae, Yoshiyuki Sawai, Yasuharu Imai, Kazuyoshi Ohkawa, Masanori Miyazaki, Satoshi Tanaka, Eiji Mita, Seiichi Tawara, Takayuki Yakushijin, Yasutoshi Nozaki, Hideki Hagiwara, Yuki Tahata, Ryoko Yamada, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara

Summary: The study found that circulating IL-6 levels may serve as a novel prognostic biomarker for predicting therapeutic response in advanced HCC patients who undergo combined immunotherapy with Atezolizumab/bevacizumab (Atezo/Bev) therapy.

CANCERS (2022)

Review Medicine, General & Internal

The First Transileocolic Obliteration for Refractory Esophageal Varices: A Case Report and Review of the Literature

Yoshifumi Fujii, Ryotaro Sakamori, Ryoko Yamada, Teppei Yoshioka, Takahiro Kodama, Minoru Shigekawa, Hayato Hikita, Satoshi Tanaka, Hisashi Ishida, Eiji Mita, Hidenari Hongyo, Hiroki Higashihara, Takehiro Noda, Hidetoshi Eguchi, Tomohide Tatsumi, Tetsuo Takehara

Summary: Transileocolic obliteration (TIO) is an effective treatment for gastric, duodenal, or rectal varices, but its application for esophageal varices has not been reported. In this study, successful TIO was performed for refractory esophageal varices with a large paraesophageal vein, with no recurrence observed afterwards.

INTERNAL MEDICINE (2022)

Article Gastroenterology & Hepatology

Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Bile Duct Via Intraductal Cooling Through an Endoscopic Nasobiliary Drainage Tube

Yusuke Seiki, Satoshi Tanaka, Seiya Kato, Akio Ishihara, Shoichi Nakazuru, Hisashi Ishida, Eiji Mita

ACG CASE REPORTS JOURNAL (2020)

Article Gastroenterology & Hepatology

Hepatocellular carcinoma in an adult patient with congenital absence of the portal vein type II: A case report

Hiroki Bessho, Satoshi Tanaka, Akio Ishihara, Shinya Kato, Reishi Toshiyama, Naoki Hama, Kiyoshi Mori, Masayuki Mano, Atsushi Miyamoto, Hisashi Ishida, Motohiro Hirao, Eiji Mita

JGH OPEN (2020)

暂无数据